Dr. Arthur Edison and Dr. Natarajan Kannan, as well as members of their labs, have contributed to a project that has resulted in a breakthrough in the treatment of leukemia. While working with Dr. Takahiro Ito, the researchers have identified a new drug target for the two most common types of myeloid leukemia. Their results have been published in Nature.
For more information, go here.
To read the publication, go here.